Warfarin-induced	warfarin-induced	O	O	O	O
leukocytoclastic	leukocytoclastic	O	O	OTHERS	I
vasculitis	vasculitis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Skin	skin	O	O	OTHERS	I
reactions	reactions	O	O	OTHERS	I
associated	associated	O	O	O	O
with	with	O	O	O	O
oral	oral	O	O	O	O
coumarin-derived	coumarin-derived	O	O	O	O
anticoagulants	anticoagulants	O	O	O	O
are	are	O	O	O	O
an	an	O	O	O	O
uncommon	uncommon	O	O	O	O
occurrence	occurrence	O	O	O	O
.	.	O	O	O	O

Leukocytoclastic	leukocytoclastic	O	O	OTHERS	I
vasculitis	vasculitis	O	DISEASE	OTHERS	I
(	(	O	O	O	O
LV	lv	O	O	OTHERS	I
)	)	O	O	O	O
is	is	O	O	O	O
primarily	primarily	O	O	O	O
a	a	O	O	O	O
cutaneous	cutaneous	O	O	OTHERS	I
small	small	O	O	OTHERS	I
vessel	vessel	O	O	OTHERS	I
vasculitis	vasculitis	O	DISEASE	OTHERS	I
,	,	O	O	O	O
though	though	O	O	O	O
systemic	systemic	O	O	O	O
involvement	involvement	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
encountered	encountered	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
report	report	O	O	O	O
4	4	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
late-onset	late-onset	O	O	O	O
LV	lv	O	O	OTHERS	I
probably	probably	O	O	O	O
due	due	O	O	O	O
to	to	O	O	O	O
warfarin	warfarin	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

All	all	O	O	O	O
4	4	O	O	O	O
patients	patients	O	O	O	O
presented	presented	O	O	O	O
with	with	O	O	O	O
skin	skin	O	O	OTHERS	I
eruptions	eruptions	O	O	OTHERS	I
that	that	O	O	O	O
developed	developed	O	O	O	O
after	after	O	O	O	O
receiving	receiving	O	O	O	O
warfarin	warfarin	CHEMICALS	O	OTHERS	I
for	for	O	O	O	O
several	several	O	O	O	O
years	years	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
results	results	O	O	O	O
of	of	O	O	O	O
skin	skin	O	O	OTHERS	I
lesion	lesion	O	O	OTHERS	I
biopsies	biopsies	O	O	O	O
were	were	O	O	O	O
available	available	O	O	O	O
in	in	O	O	O	O
3	3	O	O	O	O
patients	patients	O	O	O	O
,	,	O	O	O	O
confirming	confirming	O	O	O	O
LV	lv	O	O	OTHERS	I
Cutaneous	cutaneous	O	O	OTHERS	I
lesions	lesions	O	O	OTHERS	I
resolved	resolved	O	O	O	O
in	in	O	O	O	O
all	all	O	O	O	O
patients	patients	O	O	O	O
after	after	O	O	O	O
warfarin	warfarin	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
discontinued	discontinued	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
2	2	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
4	4	O	O	O	O
patients	patients	O	O	O	O
,	,	O	O	O	O
rechallenge	rechallenge	O	O	O	O
with	with	O	O	O	O
warfarin	warfarin	CHEMICALS	O	OTHERS	I
led	led	O	O	O	O
to	to	O	O	O	O
recurrence	recurrence	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
lesions	lesions	O	O	O	O
.	.	O	O	O	O

LV	lv	O	O	OTHERS	I
may	may	O	O	O	O
be	be	O	O	O	O
a	a	O	O	O	O
late-onset	late-onset	O	O	O	O
adverse	adverse	O	O	O	O
reaction	reaction	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
warfarin	warfarin	CHEMICALS	O	OTHERS	I
therapy	therapy	O	O	O	O
.	.	O	O	O	O

